| Product Code: ETC8545839 | Publication Date: Sep 2024 | Updated Date: Aug 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Dhaval Chaurasia | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Netherlands Pharmacogenetic Testing Market Overview |
3.1 Netherlands Country Macro Economic Indicators |
3.2 Netherlands Pharmacogenetic Testing Market Revenues & Volume, 2021 & 2031F |
3.3 Netherlands Pharmacogenetic Testing Market - Industry Life Cycle |
3.4 Netherlands Pharmacogenetic Testing Market - Porter's Five Forces |
3.5 Netherlands Pharmacogenetic Testing Market Revenues & Volume Share, By Type, 2021 & 2031F |
3.6 Netherlands Pharmacogenetic Testing Market Revenues & Volume Share, By Gene Type, 2021 & 2031F |
3.7 Netherlands Pharmacogenetic Testing Market Revenues & Volume Share, By Drug Type, 2021 & 2031F |
3.8 Netherlands Pharmacogenetic Testing Market Revenues & Volume Share, By Sample, 2021 & 2031F |
3.9 Netherlands Pharmacogenetic Testing Market Revenues & Volume Share, By Therapeutic Area, 2021 & 2031F |
3.10 Netherlands Pharmacogenetic Testing Market Revenues & Volume Share, By Application, 2021 & 2031F |
3.11 Netherlands Pharmacogenetic Testing Market Revenues & Volume Share, By End User, 2021 & 2031F |
4 Netherlands Pharmacogenetic Testing Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing demand for personalized medicine |
4.2.2 Growing awareness about the benefits of pharmacogenetic testing |
4.2.3 Government initiatives promoting precision medicine |
4.3 Market Restraints |
4.3.1 High cost associated with pharmacogenetic testing |
4.3.2 Limited insurance coverage for pharmacogenetic testing |
4.3.3 Lack of standardized guidelines for pharmacogenetic testing |
5 Netherlands Pharmacogenetic Testing Market Trends |
6 Netherlands Pharmacogenetic Testing Market, By Types |
6.1 Netherlands Pharmacogenetic Testing Market, By Type |
6.1.1 Overview and Analysis |
6.1.2 Netherlands Pharmacogenetic Testing Market Revenues & Volume, By Type, 2021- 2031F |
6.1.3 Netherlands Pharmacogenetic Testing Market Revenues & Volume, By Whole Genome Sequencing, 2021- 2031F |
6.1.4 Netherlands Pharmacogenetic Testing Market Revenues & Volume, By Whole Exome Sequencing, 2021- 2031F |
6.1.5 Netherlands Pharmacogenetic Testing Market Revenues & Volume, By Array-Based Tests, 2021- 2031F |
6.1.6 Netherlands Pharmacogenetic Testing Market Revenues & Volume, By Single Gene Tests, 2021- 2031F |
6.2 Netherlands Pharmacogenetic Testing Market, By Gene Type |
6.2.1 Overview and Analysis |
6.2.2 Netherlands Pharmacogenetic Testing Market Revenues & Volume, By CYP2C19, 2021- 2031F |
6.2.3 Netherlands Pharmacogenetic Testing Market Revenues & Volume, By CYP2D6, 2021- 2031F |
6.2.4 Netherlands Pharmacogenetic Testing Market Revenues & Volume, By CYP2C9 and VKORC1, 2021- 2031F |
6.2.5 Netherlands Pharmacogenetic Testing Market Revenues & Volume, By CYP1A2, 2021- 2031F |
6.2.6 Netherlands Pharmacogenetic Testing Market Revenues & Volume, By HLA-B*1502, 2021- 2031F |
6.2.7 Netherlands Pharmacogenetic Testing Market Revenues & Volume, By HLA-B*5701, 2021- 2031F |
6.3 Netherlands Pharmacogenetic Testing Market, By Drug Type |
6.3.1 Overview and Analysis |
6.3.2 Netherlands Pharmacogenetic Testing Market Revenues & Volume, By Prescription Drugs, 2021- 2031F |
6.3.3 Netherlands Pharmacogenetic Testing Market Revenues & Volume, By Nutraceuticals, 2021- 2031F |
6.3.4 Netherlands Pharmacogenetic Testing Market Revenues & Volume, By Recreational Drugs, 2021- 2031F |
6.3.5 Netherlands Pharmacogenetic Testing Market Revenues & Volume, By Herbal Supplements, 2021- 2031F |
6.3.6 Netherlands Pharmacogenetic Testing Market Revenues & Volume, By Vitamins, 2021- 2031F |
6.3.7 Netherlands Pharmacogenetic Testing Market Revenues & Volume, By Over-the-Counter Medications, 2021- 2031F |
6.4 Netherlands Pharmacogenetic Testing Market, By Sample |
6.4.1 Overview and Analysis |
6.4.2 Netherlands Pharmacogenetic Testing Market Revenues & Volume, By Blood, 2021- 2031F |
6.4.3 Netherlands Pharmacogenetic Testing Market Revenues & Volume, By Saliva, 2021- 2031F |
6.5 Netherlands Pharmacogenetic Testing Market, By Therapeutic Area |
6.5.1 Overview and Analysis |
6.5.2 Netherlands Pharmacogenetic Testing Market Revenues & Volume, By Cardiology, 2021- 2031F |
6.5.3 Netherlands Pharmacogenetic Testing Market Revenues & Volume, By Gastroenterology, 2021- 2031F |
6.5.4 Netherlands Pharmacogenetic Testing Market Revenues & Volume, By Anesthesiology, 2021- 2031F |
6.5.5 Netherlands Pharmacogenetic Testing Market Revenues & Volume, By Genomics, 2021- 2031F |
6.5.6 Netherlands Pharmacogenetic Testing Market Revenues & Volume, By Endocrinology, 2021- 2031F |
6.5.7 Netherlands Pharmacogenetic Testing Market Revenues & Volume, By Immunology & Hypersensitivity, 2021- 2031F |
6.5.8 Netherlands Pharmacogenetic Testing Market Revenues & Volume, By Others, 2021- 2031F |
6.5.9 Netherlands Pharmacogenetic Testing Market Revenues & Volume, By Others, 2021- 2031F |
6.6 Netherlands Pharmacogenetic Testing Market, By Application |
6.6.1 Overview and Analysis |
6.6.2 Netherlands Pharmacogenetic Testing Market Revenues & Volume, By Clinical Practice, 2021- 2031F |
6.6.3 Netherlands Pharmacogenetic Testing Market Revenues & Volume, By Drug Development, 2021- 2031F |
6.6.4 Netherlands Pharmacogenetic Testing Market Revenues & Volume, By Drug Regulation, 2021- 2031F |
6.7 Netherlands Pharmacogenetic Testing Market, By End User |
6.7.1 Overview and Analysis |
6.7.2 Netherlands Pharmacogenetic Testing Market Revenues & Volume, By Healthcare Providers, 2021- 2031F |
6.7.3 Netherlands Pharmacogenetic Testing Market Revenues & Volume, By Pharmaceutical & Biotechnology Companies, 2021- 2031F |
6.7.4 Netherlands Pharmacogenetic Testing Market Revenues & Volume, By Others, 2021- 2031F |
6.7.5 Netherlands Pharmacogenetic Testing Market Revenues & Volume, By Others, 2021- 2031F |
7 Netherlands Pharmacogenetic Testing Market Import-Export Trade Statistics |
7.1 Netherlands Pharmacogenetic Testing Market Export to Major Countries |
7.2 Netherlands Pharmacogenetic Testing Market Imports from Major Countries |
8 Netherlands Pharmacogenetic Testing Market Key Performance Indicators |
8.1 Number of healthcare providers offering pharmacogenetic testing services |
8.2 Adoption rate of pharmacogenetic testing by healthcare facilities |
8.3 Research and development investments in pharmacogenetic testing technology |
9 Netherlands Pharmacogenetic Testing Market - Opportunity Assessment |
9.1 Netherlands Pharmacogenetic Testing Market Opportunity Assessment, By Type, 2021 & 2031F |
9.2 Netherlands Pharmacogenetic Testing Market Opportunity Assessment, By Gene Type, 2021 & 2031F |
9.3 Netherlands Pharmacogenetic Testing Market Opportunity Assessment, By Drug Type, 2021 & 2031F |
9.4 Netherlands Pharmacogenetic Testing Market Opportunity Assessment, By Sample, 2021 & 2031F |
9.5 Netherlands Pharmacogenetic Testing Market Opportunity Assessment, By Therapeutic Area, 2021 & 2031F |
9.6 Netherlands Pharmacogenetic Testing Market Opportunity Assessment, By Application, 2021 & 2031F |
9.7 Netherlands Pharmacogenetic Testing Market Opportunity Assessment, By End User, 2021 & 2031F |
10 Netherlands Pharmacogenetic Testing Market - Competitive Landscape |
10.1 Netherlands Pharmacogenetic Testing Market Revenue Share, By Companies, 2024 |
10.2 Netherlands Pharmacogenetic Testing Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here